Handheld Ultrasound Scanners Receive Market Clearance
By MedImaging International staff writers Posted on 21 May 2013 |

Image: The Signos RT/Sonimage P3 device (Photo courtesy of Signostics).
Novel handheld ultrasound scanners features include patented technology and an award-winning design to provide a lightweight, handheld ultrasound device for high-quality imaging at the point-of-care for healthcare professionals, medical practitioners, and veterinarians worldwide across a wide range of clinical settings.
Handheld ultrasound device manufacturer Signostics (Thebarton, SA, Australia) has received a key boost with 510K clearance from the US Food and Drug Administration (FDA) to market its new Signos RT to the American market.
510(k) clearance from the FDA means the Signos RT can now be marketed throughout the US where it will be marketed as the Sonimage P—the brand name of Signostics’ newly appointed global partner Konica Minolta, Inc. (Tokyo, Japan).
“FDA clearance for the USA market further enhances the potential of this innovative product and will enable medical practitioners and patients throughout America to benefit from the real-time point-of-care imaging capabilities that the device provides,” said Signostics’ chief executive officer Warren Ortmann. “This clearance will help us build on the enormous interest we have already received from potential distribution partners throughout Europe, South East Asia, and our own Australian market who have seen and experienced the device first-hand. It certainly is a very important and exciting milestone for Signostics and is a fantastic boost for our new distribution partnership with Konica Minolta.”
The Signos RT/Sonimage P3 device features innovative patented technology and an award-winning design to provide a lightweight, handheld ultrasound device for high quality imaging at the point-of-care for medical practitioners, healthcare professionals, and veterinarians globally across a wide range of clinical settings.
Earlier in 2013, Signostics and Konica Minolta reported a major distribution partnership that sees Konica Minolta marketing the Signos RT/Sonimage P3 device exclusively through Japan, India, China, and the United States.
Related Links:
Signostics
Handheld ultrasound device manufacturer Signostics (Thebarton, SA, Australia) has received a key boost with 510K clearance from the US Food and Drug Administration (FDA) to market its new Signos RT to the American market.
510(k) clearance from the FDA means the Signos RT can now be marketed throughout the US where it will be marketed as the Sonimage P—the brand name of Signostics’ newly appointed global partner Konica Minolta, Inc. (Tokyo, Japan).
“FDA clearance for the USA market further enhances the potential of this innovative product and will enable medical practitioners and patients throughout America to benefit from the real-time point-of-care imaging capabilities that the device provides,” said Signostics’ chief executive officer Warren Ortmann. “This clearance will help us build on the enormous interest we have already received from potential distribution partners throughout Europe, South East Asia, and our own Australian market who have seen and experienced the device first-hand. It certainly is a very important and exciting milestone for Signostics and is a fantastic boost for our new distribution partnership with Konica Minolta.”
The Signos RT/Sonimage P3 device features innovative patented technology and an award-winning design to provide a lightweight, handheld ultrasound device for high quality imaging at the point-of-care for medical practitioners, healthcare professionals, and veterinarians globally across a wide range of clinical settings.
Earlier in 2013, Signostics and Konica Minolta reported a major distribution partnership that sees Konica Minolta marketing the Signos RT/Sonimage P3 device exclusively through Japan, India, China, and the United States.
Related Links:
Signostics
Latest Ultrasound News
- AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
- AI Identifies Heart Valve Disease from Common Imaging Test
- Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
- Ultrasound-Based Microscopy Technique to Help Diagnose Small Vessel Diseases
- Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
- Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
- High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
- World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
- Artificial Intelligence Detects Undiagnosed Liver Disease from Echocardiograms
- Ultrasound Imaging Non-Invasively Tracks Tumor Response to Radiation and Immunotherapy
- AI Improves Detection of Congenital Heart Defects on Routine Prenatal Ultrasounds
- AI Diagnoses Lung Diseases from Ultrasound Videos with 96.57% Accuracy
- New Contrast Agent for Ultrasound Imaging Ensures Affordable and Safer Medical Diagnostics
- Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors
- POC Ultrasound Enhances Early Pregnancy Care and Cuts Emergency Visits
- AI-Based Models Outperform Human Experts at Identifying Ovarian Cancer in Ultrasound Images
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more